Will Aurinia Pharma's Lupus Nephritis Drug Pass FDA Muster?

RTT News

by Super Admin 26 Views

Shares of Aurinia Pharmaceuticals Inc. (AUPH) have fallen nearly 35% from their 52-week high of $20.48 recorded on Feb.21, 2020, and trade around $13.

Comments